檢索結果 - Tim Endy
- Showing 1 - 3 results of 3
-
1
-
2
Characterising the benefits and risks of vaccines approved through accelerated pathways 由 Bethan Cracknell Daniels, Tim Endy, Joseph A. Lewnard, José Luis Di Fábio, Oscar Cortes-Azuero, Gabrielle Breugelmans, Simon Cauchemez, Alexander Roberto Precioso, Albert I. Ko, Rebecca E. Chandler, Stephen J. Thomas, Nicole Lurie, Henrik Salje
出版 2025Pré-impressão -
3
Clinical development and regulatory points for consideration for second-generation live attenuated dengue vaccines 由 Kirsten Vannice, Annelies Wilder‐Smith, Alan D.T. Barrett, Kalinka Carrijo, Marco Cavaleri, Aravinda de Silva, Anna P. Durbin, Tim Endy, Eva Harris, Bruce L. Innis, Leah C. Katzelnick, Peter G. Smith, Wellington Sun, Stephen J. Thomas, Joachim Hombach
出版 2018Artigo
相關主題
Dengue fever
Dengue virus
Immunology
Medicine
Biochemistry
Biology
Business
Clinical trial
Cytokine
Dengue vaccine
Environmental health
Immune system
In vitro
Intensive care medicine
Licensure
Nursing
Pathology
Peripheral blood mononuclear cell
Population
Public health
Risk analysis (engineering)
Subclinical infection
Vaccination
Vaccine efficacy
Virology
Virus
Whole blood